Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Fibrosis"" wg kryterium: Temat


Tytuł :
[Calpain activation promotes dialysis-associated peritoneal fibrosis in rats].
Autorzy :
Li F; Department of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Hong X; Department of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Jiang J; Department of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Pokaż więcej
Źródło :
Nan fang yi ke da xue xue bao = Journal of Southern Medical University [Nan Fang Yi Ke Da Xue Xue Bao] 2021 Apr 20; Vol. 41 (4), pp. 593-599.
Typ publikacji :
Journal Article
MeSH Terms :
Peritoneal Fibrosis*/etiology
Peritoneal Fibrosis*/pathology
Animals ; Calpain ; Fibrosis ; Male ; Peritoneum/pathology ; Rats ; Rats, Sprague-Dawley ; Renal Dialysis ; Transforming Growth Factor beta1
Czasopismo naukowe
Tytuł :
Cystic fibrosis in disguise - the wolf in sheep's clothing, a case report.
Autorzy :
Wilbert F; Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Centre - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Grünert SC; Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Centre - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Heinzmann A; Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Centre - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Bode SFN; Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Centre - University of Freiburg, Faculty of Medicine, Freiburg, Germany. .; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Centre, Ulm, Germany. .
Pokaż więcej
Źródło :
BMC pediatrics [BMC Pediatr] 2021 Apr 14; Vol. 21 (1), pp. 174. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cystic Fibrosis*/complications
Cystic Fibrosis*/diagnosis
Child ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Genetic Testing ; Humans ; Infant, Newborn ; Neonatal Screening
Czasopismo naukowe
Tytuł :
Serial changes of CT findings in patients with chronic hypersensitivity pneumonitis: imaging trajectories and predictors of fibrotic progression and acute exacerbation.
Autorzy :
Choe J; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, 138-736, Seoul, South Korea.
Chae EJ; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, 138-736, Seoul, South Korea. .
Kim YJ; Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, 138-736, Seoul, South Korea.
Do KH; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, 138-736, Seoul, South Korea.
Song JS; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, 138-736, Seoul, South Korea.
Song JW; Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, 138-736, Seoul, South Korea. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Jun; Vol. 31 (6), pp. 3993-4003. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Journal Article
MeSH Terms :
Alveolitis, Extrinsic Allergic*/diagnostic imaging
Idiopathic Pulmonary Fibrosis*/diagnostic imaging
Female ; Fibrosis ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.
Autorzy :
Lin YC; Department of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Keenan K; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Gong J; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Panjwani N; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Avolio J; Program in Translational Medicine, The Hospital for Sick Children, Toronto, ON, Canada.
Lin F; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Adam D; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.; CRCHUM, Montréal, QC, Canada.
Barrett P; IWK Health Centre, Halifax, NS, Canada.
Bégin S; CRCHUM, Montréal, QC, Canada.
Berthiaume Y; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
Bilodeau L; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Québec City, QC, Canada.
Bjornson C; Alberta Children's Hospital, Calgary, AB, Canada.
Brusky J; Jim Pattison Children's Hospital, Saskatoon, SK, Canada.
Burgess C; British Columbia Children's Hospital, Vancouver, BC, Canada.
Chilvers M; British Columbia Children's Hospital, Vancouver, BC, Canada.
Consunji-Araneta R; The Children's Hospital of Winnipeg, Winnipeg, MB, Canada.
Côté-Maurais G; CRCHUM, Montréal, QC, Canada.
Dale A; Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Donnelly C; IWK Health Centre, Halifax, NS, Canada.
Fairservice L; Alberta Children's Hospital, Calgary, AB, Canada.
Griffin K; St. Michael's Hospital, Toronto, ON, Canada.
Henderson N; Kingston Health Sciences Centre, Kingston, ON, Canada.
Hillaby A; University of Alberta Hospital, Edmonton, AB, Canada.
Hughes D; IWK Health Centre, Halifax, NS, Canada.
Iqbal S; The Children's Hospital of Winnipeg, Winnipeg, MB, Canada.
Itterman J; The Children's Hospital of Western Ontario, London, ON, Canada.
Jackson M; Royal University Hospital, Saskatoon, SK, Canada.
Karlsen E; St. Paul's Hospital, Vancouver, BC, Canada.
Kosteniuk L; Royal University Hospital, Saskatoon, SK, Canada.
Lazosky L; St. Paul's Hospital, Vancouver, BC, Canada.
Leung W; University of Alberta Hospital, Edmonton, AB, Canada.
Levesque V; Foothills Medical Centre, Calgary, AB, Canada.
Maille É; CRCHUM, Montréal, QC, Canada.
Mateos-Corral D; IWK Health Centre, Halifax, NS, Canada.
McMahon V; British Columbia Children's Hospital, Vancouver, BC, Canada.
Merjaneh M; CRCHUM, Montréal, QC, Canada.
Morrison N; Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Parkins M; Foothills Medical Centre, Calgary, AB, Canada.
Pike J; St. Michael's Hospital, Toronto, ON, Canada.
Price A; The Children's Hospital of Western Ontario, London, ON, Canada.
Quon BS; St. Paul's Hospital, Vancouver, BC, Canada.
Reisman J; The Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
Smith C; Foothills Medical Centre, Calgary, AB, Canada.
Smith MJ; Janeway Children's Health & Rehabilitation Centre, St. John's, NL, Canada.
Vadeboncoeur N; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Québec City, QC, Canada.
Veniott D; St. Mary's General Hospital, Kitchener, ON, Canada.
Viczko T; British Columbia Children's Hospital, Vancouver, BC, Canada.
Wilcox P; St. Paul's Hospital, Vancouver, BC, Canada.
van Wylick R; Kingston Health Sciences Centre, Kingston, ON, Canada.
Cutting G; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Tullis E; St. Michael's Hospital, Toronto, ON, Canada.
Ratjen F; Program in Translational Medicine, The Hospital for Sick Children, Toronto, ON, Canada.; Division of Respiratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.
Rommens JM; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Sun L; Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada.
Solomon M; Division of Respiratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.
Stephenson AL; St. Michael's Hospital, Toronto, ON, Canada.
Brochiero E; Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.; CRCHUM, Montréal, QC, Canada.
Blackman S; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Corvol H; Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Pediatric Pulmonary Department, Paris, France.; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre de Recherche Saint Antoine, Paris, France.
Strug LJ; Department of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. .; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada. .; Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada. .; The Center for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada. .; Department of Computer Science, University of Toronto, Toronto, ON, Canada. .
Pokaż więcej
Źródło :
Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2021 May; Vol. 23 (5), pp. 927-933. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cystic Fibrosis*/complications
Cystic Fibrosis*/diagnosis
Cystic Fibrosis*/genetics
Diabetes Mellitus*/epidemiology
Diabetes Mellitus*/genetics
Biomarkers ; Canada ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Genome-Wide Association Study ; Humans ; Infant, Newborn
Czasopismo naukowe
Tytuł :
Lives changed: A new era for people with cystic fibrosis.
Autorzy :
Louey S; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.
Massie J; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.; Respiratory Diseases, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
Journal of paediatrics and child health [J Paediatr Child Health] 2021 Jun; Vol. 57 (6), pp. 968-970. Date of Electronic Publication: 2021 Apr 23.
Typ publikacji :
Letter
MeSH Terms :
Cystic Fibrosis*
Cystic Fibrosis Transmembrane Conductance Regulator ; Humans
Opinia redakcyjna
Tytuł :
Pseudo-Bartter Syndrome and Intermediate Sweat Chloride Levels-It Could Still be Cystic Fibrosis!
Autorzy :
Kumar M; Department of Pediatrics, Christian Medical College, Vellore, 632004, Tamil Nadu, India.
Varkki SD; Department of Pediatrics, Christian Medical College, Vellore, 632004, Tamil Nadu, India. .
Pokaż więcej
Źródło :
Indian journal of pediatrics [Indian J Pediatr] 2021 Jun; Vol. 88 (6), pp. 600. Date of Electronic Publication: 2021 Apr 07.
Typ publikacji :
Letter
MeSH Terms :
Bartter Syndrome*/diagnosis
Cystic Fibrosis*/diagnosis
Chlorides ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Humans ; Mutation ; Sweat
Opinia redakcyjna
Tytuł :
Cystic fibrosis in Brazil: achievements in survival.
Autorzy :
Vendrusculo FM; Centro Infant, Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre (RS) Brasil.
Donadio MVF; Centro Infant, Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre (RS) Brasil.
Pinto LA; Centro Infant, Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre (RS) Brasil.
Pokaż więcej
Źródło :
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia [J Bras Pneumol] 2021 Apr 30; Vol. 47 (2), pp. e20210140. Date of Electronic Publication: 2021 Apr 30.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Cystic Fibrosis*
Brazil/epidemiology ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Humans ; Mutation
Opinia redakcyjna
Tytuł :
Racially equitable diagnosis of cystic fibrosis using next-generation DNA sequencing: a case report.
Autorzy :
Shum BOV; Preventive Health Division, Genepath, 302B 7 Help St, Chatswood, NSW, Australia. .; EMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia. .
Bennett G; Preventive Health Division, Genepath, 302B 7 Help St, Chatswood, NSW, Australia.
Navilebasappa A; Acquity Labs, 515, 4th Block HBR layout, Bengaluru, Karnataka, India.
Kumar RK; Cloudnine Hospitals, 1533, 3rd Block, Jayanagar, Bengaluru, Karnataka, India.
Pokaż więcej
Źródło :
BMC pediatrics [BMC Pediatr] 2021 Mar 31; Vol. 21 (1), pp. 154. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cystic Fibrosis*/diagnosis
Cystic Fibrosis*/genetics
Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; DNA ; Female ; Humans ; India ; Infant, Newborn ; Mutation ; Sequence Analysis, DNA
Czasopismo naukowe
Tytuł :
[Cystic fibrosis prognosis in Europa : chronicle of an announced dilemma].
Autorzy :
Lebecque P; Unité de Pneumologie pédiatrique et Mucoviscidose, MontLégia, Liège, Belgique.
Thimmesch M; Unité de Pneumologie pédiatrique et Mucoviscidose, MontLégia, Liège, Belgique.
Pokaż więcej
Transliterated Title :
Modulateurs et pronostic de la mucoviscidose en Europe : chronique d’un dilemme annoncé.
Źródło :
Revue medicale de Liege [Rev Med Liege] 2021 Mar; Vol. 76 (3), pp. 202-207.
Typ publikacji :
Journal Article
MeSH Terms :
Cystic Fibrosis*/diagnosis
Cystic Fibrosis*/therapy
Quinolones*
Aminophenols ; Aminopyridines ; Benzodioxoles ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Europe ; Humans ; Mutation ; Prognosis
Czasopismo naukowe
Tytuł :
Cystic fibrosis drug approved for patients aged 6-11 years worked well in clinical practice.
Autorzy :
Loukou I; Cystic Fibrosis Department, Agia Sofia Children's Hospital, Athens, Greece.
Petrocheilou A; Cystic Fibrosis Department, Agia Sofia Children's Hospital, Athens, Greece.
Moustaki M; Cystic Fibrosis Department, Agia Sofia Children's Hospital, Athens, Greece.
Katsagoni CN; Cystic Fibrosis Department, Agia Sofia Children's Hospital, Athens, Greece.
Douros K; Pediatric Allergy and Respiratory Unit, 3rd Department of Pediatrics, School of Medicine, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Pokaż więcej
Źródło :
Acta paediatrica (Oslo, Norway : 1992) [Acta Paediatr] 2021 Jan; Vol. 110 (1), pp. 228-229. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :
Journal Article
MeSH Terms :
Cystic Fibrosis*/drug therapy
Pharmaceutical Preparations*
Child ; Cystic Fibrosis Transmembrane Conductance Regulator ; Humans
Czasopismo naukowe
Tytuł :
Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
Autorzy :
Staufer K; Department of Visceral Surgery and Medicine, Inselspital, University Hospital Bern, 3010 Bern, Switzerland; ; Tel.: +41-31-63-2-74-88.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Nov 14; Vol. 21 (22). Date of Electronic Publication: 2020 Nov 14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cystic Fibrosis*/complications
Cystic Fibrosis*/genetics
Cystic Fibrosis*/metabolism
Cystic Fibrosis*/therapy
Liver Diseases*/etiology
Liver Diseases*/genetics
Liver Diseases*/metabolism
Liver Diseases*/pathology
Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Cystic Fibrosis Transmembrane Conductance Regulator/metabolism ; Humans ; Ursodeoxycholic Acid/therapeutic use
Czasopismo naukowe
Tytuł :
A systematic review of the clinical and genetic characteristics of Chinese patients with cystic fibrosis.
Autorzy :
Shi R; Division of Pulmonology, Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wang X; Division of Pulmonology, Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lu X; Division of Pulmonology, Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhu Z; Division of Pulmonology, Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xu Q; Division of Pulmonology, Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wang H; Division of Pulmonology, Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Song L; Division of Pulmonology, Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhu C; Department of Neonatology, Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Zhengzhou, China.
Pokaż więcej
Źródło :
Pediatric pulmonology [Pediatr Pulmonol] 2020 Nov; Vol. 55 (11), pp. 3005-3011. Date of Electronic Publication: 2020 Jul 31.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Asian Continental Ancestry Group*/genetics
Cystic Fibrosis*/diagnosis
Cystic Fibrosis*/genetics
Cystic Fibrosis*/microbiology
Bacterial Infections/diagnosis ; Bacterial Infections/genetics ; Bacterial Infections/microbiology ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Humans
Czasopismo naukowe
Tytuł :
Non-viral mediated gene therapy in human cystic fibrosis airway epithelial cells recovers chloride channel functionality.
Autorzy :
Sainz-Ramos M; NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain.
Villate-Beitia I; NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain.
Gallego I; NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain.
A L Qtaish N; NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
Lopez-Mendez TB; NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain.
Eritja R; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain; Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
Grijalvo S; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain; Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
Puras G; NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain. Electronic address: .
Pedraz JL; NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2020 Oct 15; Vol. 588, pp. 119757. Date of Electronic Publication: 2020 Aug 10.
Typ publikacji :
Journal Article
MeSH Terms :
Chloride Channels*/genetics
Cystic Fibrosis*/genetics
Cystic Fibrosis*/therapy
Genetic Therapy*
Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Epithelial Cells ; Humans ; Respiratory System
Czasopismo naukowe
Tytuł :
Sustained recovery of exocrine pancreatic function in a teenager with cystic fibrosis treated with ivacaftor.
Autorzy :
Smith H; Faculty of Medicine, MD Undergraduate Program, University of British Columbia, Vancouver, British Columbia, Canada.
Rayment JH; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.; Division of Respiratory Medicine, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
Pokaż więcej
Źródło :
Pediatric pulmonology [Pediatr Pulmonol] 2020 Oct; Vol. 55 (10), pp. 2493-2494. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji :
Letter; Comment
MeSH Terms :
Cystic Fibrosis*/drug therapy
Cystic Fibrosis*/genetics
Gastrointestinal Microbiome*
Adolescent ; Aminophenols/therapeutic use ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Humans ; Quinolones
Opinia redakcyjna
Tytuł :
Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody.
Autorzy :
Venosa A; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA.
Gow JG; Dartmouth College, Hanover, NH 03755, USA.
Taylor S; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Golden TN; Center for Research on Reproduction and Women's Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 18015, USA.
Murray A; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Abramova E; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Malaviya R; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Laskin DL; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Gow AJ; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: .
Pokaż więcej
Źródło :
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2021 Apr 15; Vol. 417, pp. 115470. Date of Electronic Publication: 2021 Feb 27.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Anti-Inflammatory Agents/*pharmacology
Lung/*drug effects
Macrophage Activation/*drug effects
Macrophages/*drug effects
Pneumonia/*prevention & control
Pulmonary Fibrosis/*prevention & control
Tumor Necrosis Factor Inhibitors/*pharmacology
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
Animals ; Bleomycin ; Disease Models, Animal ; Epithelial Cells/drug effects ; Epithelial Cells/metabolism ; Epithelial Cells/pathology ; Fibrosis ; Lung/metabolism ; Lung/pathology ; Macrophages/metabolism ; Macrophages/pathology ; Male ; Mice, Inbred C57BL ; Phenotype ; Phospholipids/metabolism ; Pneumonia/chemically induced ; Pneumonia/metabolism ; Pneumonia/pathology ; Pulmonary Fibrosis/chemically induced ; Pulmonary Fibrosis/metabolism ; Pulmonary Fibrosis/pathology ; Pulmonary Surfactant-Associated Proteins/metabolism ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł :
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.
Autorzy :
Bellocchi C; The University of Texas Health Science Center at Houston and McGovern Medical School, Houston, and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
Ying J; The University of Texas Health Science Center at Houston and McGovern Medical School, Houston.
Goldmuntz EA; National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland.
Keyes-Elstein L; Rho Federal Systems Division, Inc., Durham, North Carolina.
Varga J; Northwestern University, Chicago, Illinois.
Hinchcliff ME; Yale University School of Medicine, New Haven, Connecticut.
Lyons MA; The University of Texas Health Science Center at Houston and McGovern Medical School, Houston.
McSweeney P; Colorado Blood Cancer Institute, Denver.
Furst DE; University of California Los Angeles, University of Washington, Seattle, and University of Florence, Florence, Italy.
Nash R; Colorado Blood Cancer Institute, Denver.
Crofford LJ; Vanderbilt University Medical Center, Nashville, Tennessee.
Welch B; National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland.
Goldin JG; University of California Los Angeles.
Pinckney A; Rho Federal Systems Division, Inc., Durham, North Carolina.
Mayes MD; The University of Texas Health Science Center at Houston and McGovern Medical School, Houston.
Sullivan KM; Duke University, Durham, North Carolina.
Assassi S; The University of Texas Health Science Center at Houston and McGovern Medical School, Houston.
Pokaż więcej
Źródło :
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Apr; Vol. 73 (4), pp. 660-670. Date of Electronic Publication: 2021 Feb 28.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Transcriptome*
Chemokines/*blood
Cytokines/*blood
Fibrosis/*metabolism
Lung/*pathology
Scleroderma, Systemic/*metabolism
Skin/*pathology
Adult ; Female ; Fibrosis/blood ; Fibrosis/pathology ; Humans ; Male ; Middle Aged ; Pulmonary Fibrosis/metabolism ; Pulmonary Fibrosis/pathology ; Scleroderma, Systemic/blood ; Scleroderma, Systemic/pathology ; Skin Diseases/metabolism ; Skin Diseases/pathology
Czasopismo naukowe
Tytuł :
Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis.
Autorzy :
Tétard C; CHU Bordeaux, CRCM Pédiatrique, CIC 1401, Bordeaux.
Mittaine M; CHU Toulouse, CRCM Pédiatrique, Toulouse.
Bui S; CHU Bordeaux, CRCM Pédiatrique, CIC 1401, Bordeaux.
Beaufils F; CHU Bordeaux, CRCM Pédiatrique, CIC 1401, Bordeaux.; University Bordeaux, INSERM, CRCTB, U1045, CHU Bordeaux.; FHU ACRONIM, Bordeaux.
Maumus P; CHU Toulouse, CRCM Pédiatrique, Toulouse.
Fayon M; CHU Bordeaux, CRCM Pédiatrique, CIC 1401, Bordeaux.; University Bordeaux, INSERM, CRCTB, U1045, CHU Bordeaux.; FHU ACRONIM, Bordeaux.
Burgel PR; Assistance Publique Hôpitaux de Paris (AP-HP), Respiratory Medicine and National Reference Cystic Fibrosis Reference Center, Cochin Hospital, Paris.; ERN-Lung CF network.
Lamireau T; CHU Bordeaux, CRCM Pédiatrique, CIC 1401, Bordeaux.; FHU ACRONIM, Bordeaux.
Delhaes L; CHU Bordeaux, CRCM Pédiatrique, CIC 1401, Bordeaux.; University Bordeaux, INSERM, CRCTB, U1045, CHU Bordeaux.; FHU ACRONIM, Bordeaux.; CHU Bordeaux, Service de Parasitologie-Mycologie, Bordeaux.
Mas E; CHU Toulouse, CRCM Pédiatrique, Toulouse.; Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse.; CHU de Toulouse, Unité de Gastroentérologie, Hépatologie, Nutrition, Diabétologie et Maladies Héréditaires du Métabolisme, Hôpital des Enfants, F-31300, France.
Enaud R; CHU Bordeaux, CRCM Pédiatrique, CIC 1401, Bordeaux.; University Bordeaux, INSERM, CRCTB, U1045, CHU Bordeaux.; FHU ACRONIM, Bordeaux.
Pokaż więcej
Źródło :
Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2020 Dec; Vol. 71 (6), pp. 778-781.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Aminophenols*/therapeutic use
Aminopyridines*/therapeutic use
Benzodioxoles*/therapeutic use
Cystic Fibrosis*/complications
Cystic Fibrosis*/drug therapy
Quinolones*/therapeutic use
Adolescent ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Humans ; Inflammation/drug therapy ; Lung ; Mutation
Czasopismo naukowe
Tytuł :
Retroperitoneal Metastasis, with Marked Fibrosis, of Lung Adenocarcinoma after Afatinib Treatment: An Autopsy Case Report.
Autorzy :
Ota H; Department of Respiratory Medicine, Japanese Red Cross Society, Omori Red Cross Hospital, Japan.
Ota T; Department of Respiratory Medicine, Japanese Red Cross Society, Omori Red Cross Hospital, Japan.
Narisawa E; Department of Respiratory Medicine, Japanese Red Cross Society, Omori Red Cross Hospital, Japan.
Chiba H; Department of Gastroenterology, Japanese Red Cross Society, Omori Red Cross Hospital, Japan.
Nakayama H; Department of Surgery, Japanese Red Cross Society, Omori Red Cross Hospital, Japan.
Tsukumo Y; Department of Pathology, Japanese Red Cross Society, Omori Red Cross Hospital, Japan.
Sakamoto A; Department of Pathology, Japanese Red Cross Society, Omori Red Cross Hospital, Japan.
Honma N; Department of Pathology, Toho University School of Medicine, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2020 Nov 15; Vol. 59 (22), pp. 2915-2919. Date of Electronic Publication: 2020 Jul 28.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/drug therapy
Lung Neoplasms*/drug therapy
Retroperitoneal Fibrosis*
Retroperitoneal Neoplasms*
Afatinib ; Aged ; Autopsy ; ErbB Receptors ; Female ; Fibrosis ; Humans
Czasopismo naukowe
Tytuł :
Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims database.
Autorzy :
Smith A; Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James's Hospital, University of Dublin Trinity College, Dublin, Ireland .; Medicines Management Programme, Health Service Executive, Dublin, Ireland.
Barry M; Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James's Hospital, University of Dublin Trinity College, Dublin, Ireland.; Medicines Management Programme, Health Service Executive, Dublin, Ireland.; National Centre for Pharmacoeconomics, St. James's Hospital, Dublin, Ireland.
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2020 Nov 14; Vol. 10 (11), pp. e040806. Date of Electronic Publication: 2020 Nov 14.
Typ publikacji :
Journal Article
MeSH Terms :
Cystic Fibrosis*/drug therapy
Pharmacy*
Cost-Benefit Analysis ; Cystic Fibrosis Transmembrane Conductance Regulator ; Health Expenditures ; Humans ; Ireland ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Localized peripheral autonomous neuropathy and dysfunctional myoepithelial cells: A novel hypothesis for xerostomia in oral submucous fibrosis.
Autorzy :
Sarode GS; Department of Oral Pathology and Microbiology, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Sant-Tukaram Nagar, Pimpri, Pune 411018, MH, India.
Sarode SC; Department of Oral Pathology and Microbiology, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Sant-Tukaram Nagar, Pimpri, Pune 411018, MH, India. Electronic address: .
Gadbail A; Department of Dentistry, Indira Gandhi Government Medical College and Hospital, Nagpur, Maharashtra, India.
Gondivkar S; Department of Oral Medicine and Radiology, Government Dental College & Hospital, Nagpur, Maharashtra, India.
Patil S; Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan, Saudi Arabia.
Pokaż więcej
Źródło :
Medical hypotheses [Med Hypotheses] 2020 Nov; Vol. 144, pp. 109998. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article
MeSH Terms :
Oral Submucous Fibrosis*
Xerostomia*
Fibrosis ; Humans ; Quality of Life ; Saliva
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies